2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 68, Issue 1, Pages 1-26
Publisher
Wiley
Online
2015-11-07
DOI
10.1002/art.39480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2015*
- (2015) David K. Kim et al. ANNALS OF INTERNAL MEDICINE
- FRI0261 Tnf Inhibitor Therapy and Risk of Breast Cancer Recurrence in Patients with Rheumatoid Arthritis– A Nationwide Cohort Study
- (2014) P. Raaschou et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy
- (2014) Huifeng Yun et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
- (2014) P Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial
- (2014) F. Iannone et al. JOURNAL OF RHEUMATOLOGY
- Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial
- (2014) Hideto Kameda et al. Modern Rheumatology
- Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study
- (2014) Hiroki Wakabayashi et al. Modern Rheumatology
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis
- (2014) Paul Emery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients
- (2014) Tomohiro Kameda et al. ARTHRITIS CARE & RESEARCH
- Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
- (2013) Marije F. Bakker ANNALS OF INTERNAL MEDICINE
- Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
- (2013) Joel Kremer et al. ANNALS OF INTERNAL MEDICINE
- Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
- (2013) Frank Buttgereit et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
- (2013) Michael Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
- (2013) Leslie R Harrold et al. ANNALS OF THE RHEUMATIC DISEASES
- Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four-month phase III randomized radiographic study
- (2013) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
- (2013) Jeffrey C. Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
- (2013) Jeff Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
- (2013) Yi-Hsiang Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
- (2013) Gerd R Burmester et al. LANCET
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
- (2013) Josef S Smolen et al. LANCET
- Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
- (2013) Josef S Smolen et al. LANCET
- Management of patients with hepatitis B who require immunosuppressive therapy
- (2013) Jessica P. Hwang et al. Nature Reviews Gastroenterology & Hepatology
- Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
- (2013) James R. O'Dell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis
- (2013) Kyung-Wook Jo et al. RESPIRATORY MEDICINE
- Rituximab versus anti-TNF in patients who previously failed one TNF inhibitor in an observational cohort
- (2013) K Chatzidionysiou et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis
- (2013) Stephen S. Johnston et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review
- (2013) Maurizio Pompili WORLD JOURNAL OF GASTROENTEROLOGY
- Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
- (2013) P. Raaschou et al. BMJ-British Medical Journal
- Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions
- (2013) Holger J. Schünemann et al. Research Synthesis Methods
- Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial
- (2012) P H de Jong et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
- (2012) Juan J Gomez-Reino et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
- (2012) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
- (2012) Larry W. Moreland et al. ARTHRITIS AND RHEUMATISM
- The Influence of Anti-TNF Therapy on the Course of Chronic Hepatitis C Virus Infection in Patients with Inflammatory Bowel Disease
- (2012) Ming Valerie Lin et al. DIGESTIVE DISEASES AND SCIENCES
- Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases
- (2012) Jie Zhang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
- (2012) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
- (2012) Ronald F van Vollenhoven et al. LANCET
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
- (2012) Jaclyn Anderson et al. ARTHRITIS CARE & RESEARCH
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis. Results of a 12 month open-label randomized study.
- (2012) Carlomaurizio Montecucco et al. ARTHRITIS RESEARCH & THERAPY
- Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate
- (2011) E. Coulson et al. ANNALS OF THE RHEUMATIC DISEASES
- Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
- (2011) J.-L. Lan et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
- (2011) Meliha Crnkic Kapetanovic et al. ARTHRITIS AND RHEUMATISM
- Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients
- (2011) Mikkel Østergaard et al. ARTHRITIS AND RHEUMATISM
- American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
- (2011) David T. Felson et al. ARTHRITIS AND RHEUMATISM
- A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
- (2011) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs
- (2011) Roy Fleischmann et al. ARTHRITIS AND RHEUMATISM
- Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts
- (2011) Akihiro Tamori et al. JOURNAL OF GASTROENTEROLOGY
- Tocilizumab Monotherapy Reduces Arterial Stiffness as Effectively as Etanercept or Adalimumab Monotherapy in Rheumatoid Arthritis: An Open-label Randomized Controlled Trial
- (2011) KENSUKE KUME et al. JOURNAL OF RHEUMATOLOGY
- Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy
- (2011) Roberto Pérez-Alvarez et al. MEDICINE
- Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients
- (2011) Christiane Aguiar Nobre et al. RHEUMATOLOGY INTERNATIONAL
- Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate
- (2011) Yoshiya Tanaka et al. ARTHRITIS CARE & RESEARCH
- The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study
- (2011) Jie Zhang et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
- (2010) A. M. Evens et al. ANNALS OF ONCOLOGY
- Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis
- (2010) Monica Todoerti et al. Annals of the New York Academy of Sciences
- Golimumab, a new human anti-tumor necrosis factor α antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study
- (2010) Joel Kremer et al. ARTHRITIS AND RHEUMATISM
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment
- (2010) B. Denis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: Observational study of 30 cases in everyday practice
- (2010) Éric Toussirot et al. JOINT BONE SPINE
- GRADE guidelines: 2. Framing the question and deciding on important outcomes
- (2010) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
- (2009) A Finckh et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: A long-term followup study of thirty-two patients
- (2009) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
- (2009) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients
- (2009) Sophia Li et al. CLINICAL RHEUMATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- Safety of Etanercept in Patients at High Risk for Mycobacterial Tuberculosis Infections
- (2009) R. AGGARWAL et al. JOURNAL OF RHEUMATOLOGY
- Golimumab, a human antibody to tumour necrosis factor given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
- (2008) E C Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Triple therapy in early active rheumatoid arthritis: A randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies
- (2008) S. A. Saunders et al. ARTHRITIS AND RHEUMATISM
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases
- (2008) I. Cavazzana et al. AUTOIMMUNITY REVIEWS
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now